Encompass Health (EHC) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Encompass Health Q3 Earnings Beat on Higher Discharges, Stock Up 6.3%
EHC's third-quarter results benefit from improved patient discharges. Higher operating expenses act as a partial offset.
Encompass Health Corporation (EHC) Q3 2024 Earnings Call Transcript
Encompass Health Corporation (NYSE:EHC ) Q3 2024 Earnings Conference Call October 29, 2024 10:00 AM ET Company Participants Mark Miller - Chief Investor Relations Officer Mark Tarr - President and Chief Executive Officer Douglas Coltharp - Executive Vice President and Chief Financial Officer Conference Call Participants Christian Porter - Bank of America Securities Andrew Mok - Barclays Michael Murray - RBC Capital Markets Meghan Holtz - Jefferies Kieran Ryan - Deutsche Bank Scott Fidel - Stephens Jared Haase - William Blair Zach Haggerty - KeyBanc Capital Markets Operator Good morning, everyone, and welcome to Encompass Health's Third Quarter 2024 Earnings Conference Call. At this time, I would like to inform all participants that their lines will be in a listen-only mode.
Compared to Estimates, Encompass Health (EHC) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Encompass Health (EHC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Encompass Health (EHC) Tops Q3 Earnings and Revenue Estimates
Encompass Health (EHC) came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $0.94 per share. This compares to earnings of $0.86 per share a year ago.
Are Investors Undervaluing Encompass Health (EHC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Insights Into Encompass Health (EHC) Q3: Wall Street Projections for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Encompass Health (EHC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
EHC vs. ASTH: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Encompass Health (EHC) and Astrana Health, Inc. (ASTH). But which of these two stocks offers value investors a better bang for their buck right now?
Encompass Health (EHC) Earnings Expected to Grow: Should You Buy?
Encompass Health (EHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Encompass Health (EHC) Beat Estimates Again in Its Next Earnings Report?
Encompass Health (EHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why Encompass Health (EHC) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
